转化生长因子在静脉血栓的形成和分辨率
Jonathan Davis1, Molly Maranto2, Jonathan Kennedy3
1Cardiovascular Translational Research Center (J.D., C.E.E.), University of South Carolina School of Medicine, Columbia.
Arteriosclerosis, thrombosis, and vascular biology
|March 20, 2025
概括
转化生长因子-β1 (TGF-β1) 促进深静脉血栓 (DVT) 的形成,并阻碍其解决. 向TGF-β1可能为DVT提供新的治疗策略.
科学领域:
- 血管生物学和血栓形成研究.
- 炎症性细胞因子信号通路.
- 静脉血栓栓塞的分子机制.
背景情况:
- 深静脉血栓症 (DVT) 是一种常见的血管封闭性疾病,对公共健康有重大影响.
- 目前的DVT治疗受到出血风险和慢血栓分辨率的限制.
- 炎症性细胞因子,特别是转化生长因子-β (TGF-β) 家族,在DVT的发病过程中起着至关重要的作用.
研究的目的:
- 审查TGF-β异型在静脉血栓形成和解决中的作用.
- 探索TGF-β家族成员作为DVT的治疗点的潜力.
- 确定TGF-β介导DVT的未来研究方向.
主要方法:
- 对调查TGF-β异型在静脉血栓形成中的研究的文献综述.
- 对TGF-β1在血栓形成和分离中的作用的实验数据的分析.
- 检查TGF-β1抑制或淘汰对DVT负担的影响.
主要成果:
- TGF-β1是一个关键的调节剂,促进DVT的形成并抑制其分辨率.
- 在静脉血栓形成期间观察到TGF-β1表达的增加.
- 在实验模型中,抑制或淘汰TGF-β1有效降低了血栓负担.
结论:
- TGF-β1是一种有前途的诊断标志物和DVT的治疗点.
- 需要进一步的研究来阐明TGF-β2和TGF-β3在DVT中的作用.
- 向TGF-β异型可能会导致具有更好的疗效和安全性配置的新型DVT治疗.
相关概念视频
01:16Clot Retraction and Fibrinolysis
3.1K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
3.1K
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
585
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
585
01:20Extrinsic and Intrinsic Pathways of Hemostasis
4.4K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
4.4K
01:24Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
01:22Formation of the Platelet Plug
3.5K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
3.5K
01:09Coagulation
3.9K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
3.9K